The progress of 24 children with acute lymphoblastic leukemia treated with cyclophosphamide, total-body irradiation, and marrow transplantation during a second or subsequent remission was compared with that of 21 children treated with conventional chemotherapy after they had entered a second remission. Eleven of the transplantation group are alive, including nine in continuing complete remission for 17 to 55 months; only two of the chemotherapy group are alive, one in complete remission after 20 months. Relapse was the major cause of failure in both groups. Acute and chronic graft-versus-host disease in the transplantation group and leukoencephalopathy in both groups were the other major causes of morbidity and mortality. This study demonstrates that marrow transplantation currently offers the best chance of long-term remission and potential cure after a child with acute lymphoblastic leukemia has had a relapse in the marrow.
This article has been cited by other articles:
Boulad, F., Steinherz, P., Reyes, B., Heller, G., Gillio, A. P., Small, T. N., Brochstein, J. A., Kernan, N. A., O'Reilly, R. J.
(1999). Allogeneic Bone Marrow Transplantation Versus Chemotherapy for the Treatment of Childhood Acute Lymphoblastic Leukemia in Second Remission: A Single-Institution Study. JCO
17: 197-197
[Abstract][Full Text]
Pinkel, D., Johnson, F. L., Thomas, E. D., Barrett, A. J., Pollock, B. H., Buchanan, G. R.
(1995). Treatment of Acute Lymphoblastic Leukemia in a Second Remission. NEJM
332: 823-824
[Full Text]
Barrett, A. J., Horowitz, M. M., Pollock, B. H., Zhang, M.-J., Bortin, M. M., Buchanan, G. R., Camitta, B. M., Ochs, J., Graham-Pole, J., Rowlings, P. A., Rimm, A. A., Klein, J. P., Shuster, J. J., Sobocinski, K. A., Gale, R. P.
(1994). Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission. NEJM
331: 1253-1258
[Abstract][Full Text]
MEYERS, J. D., FLOURNOY, N., SANDERS, J. E., McGUFFIN, R. W., NEWTON, B. A., FISHER, L. D., LUM, L. G., APPELBAUM, F. R., DONEY, K., SULLIVAN, K. M., STORB, R., BUCKNER, C. D., THOMAS, E. D.
(1987). Prophylactic Use of Human Leukocyte Interferon After Allogeneic Marrow Transplantation. ANN INTERN MED
107: 809-816
[Abstract]
Shannon, K. M., Cowan, M. J., Matthay, K. K.
(1987). Pediatric Bone Marrow Transplantation: Intensive Care Management. J Intensive Care Med
2: 328-344
[Abstract]
(1984). Diagnostic and Therapeutic Technology Assessment (DATTA). JAMA
251: 2155-2155
WADE, J. C., MEYERS, J. D.
(1983). Neurologic Symptoms Associated with Parenteral Acyclovir Treatment After Marrow Transplantation. ANN INTERN MED
98: 921-925
[Abstract]
Insel, R. A., Gigliotti, F.
(1983). Monoclonal Antibodies: Clinical Relevance to Pediatrics. Arch Pediatr Adolesc Med
137: 69-76
[Abstract]
Previous
